US95075A1079 - Common Stock
WEREWOLF THERAPEUTICS INC
NASDAQ:HOWL (5/1/2024, 5:14:51 PM)
After market: 6.33 +0.31 (+5.15%)6.02
-0.22 (-3.53%)
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is headquartered in Watertown, Massachusetts and currently employs 46 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm is leveraging its PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the objective of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to activate selectively in the tumor microenvironment. Its clinical-stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and IL-12 INDUKINE molecules, respectively, for the treatment of solid tumors. The company is focused on advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor and WTX-330 in multiple tumor types or Non-Hodgkin Lymphoma as a single agent. Its pipeline also includes JZP898 and WTX-712.
WEREWOLF THERAPEUTICS INC
200 Talcott Avenue, 2nd Floor
Watertown MASSACHUSETTS 02138
P: 16179520555
CEO: Daniel J. Hicklin
Employees: 46
Website: https://werewolftx.com/
Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic solid tumors WATERTOWN,...
WTX-518, a conditionally activated IL-18 INDUKINETM molecule that resists suppression by IL-18BP, led to complete tumor regressions in preclinical models
Here you can normally see the latest stock twits on HOWL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: